Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs
Aim. Most calcium antagonists do not seem to reduce microalbuminuria or proteinuria. We have tried to assess the antiproteinuric effect of a calcium channel blocker, lercanidipine, in patients previously treated with ACE inhibitors or angiotensin receptor blockers. Design and methods. The study incl...
Main Authors: | N. R. Robles, B. Romero, E. Garcia de Vinuesa, E. Sánchez-Casado, J. J. Cubero |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2011-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1838 |
Similar Items
-
CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01) -
ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION TREATED WITH LERCANIDIPINE
by: J. Tisaire-Sánchez, et al.
Published: (2011-04-01) -
Lercanidipine in arterial hypertension
by: C. Borghi
Published: (1970-01-01) -
Lercanidipine in patients with chronic renal failure: the ZAFRA Study
by: N. R. Robles, et al.
Published: (2010-08-01) -
LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01)